LABORATORY PRODUCTS ASSOCIATION

Lobbying Spend

—

Filings

Firms Hired

Active Period

2019–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	3	1
2025	—	5	2
2024	—	4	1
2023	—	4	1
2022	—	6	2
2021	—	4	1
2020	—	4	1
2019	—	5	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	31
SENATE	31
Natl Institutes of Health (NIH)	10

Most frequently reported lobbying issues

Issue Code	Description	Reports
Budget/Appropriations	Budget/Appropriations	34
Health Issues	Health Issues	16
Taxation/Internal Revenue Code	Taxation/Internal Revenue Code	16
Chemicals/Chemical Industry	Chemicals/Chemical Industry	13
Economics/Economic Development	Economics/Economic Development	2

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 2617117th Congress

Consolidated Appropriations Act, 2023

2022 · fourth_quarter · Firm: PLATINUM ADVISORS DC, LLC

Cited source text and reported amounts

Issues related to laboratory product services. Support R&D funding in HR. 2617 - Consolidated Appropriations Act.

Client expense: — · Firm income: $60,000

Matched citations: HR. 2617

LABORATORY PRODUCTS ASSOCIATION — Lobbying Disclosure | Poliscope